Roles of platelet-activating factor, interleukin-1β and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion

Journal of Surgical Research

Volumn 87, Issue 1, 1999, Pages 90-100

  Sun, Zhengwu ^a   Wang, Xiangdong ^a   Lasson, Åke ^a   Börjesson, Anna ^a   Leveau, Per ^a   Haraldsen, Pernille ^a   Andersson, Roland ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokine; Intestinal barrier; Leukocyte; Permeability; Platelet activating factor antagonist; Protease inhibitors

Indexed keywords

ALBUMIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM; INTESTINE; INTESTINE EPITHELIUM; INTESTINE MUCOSA; ISCHEMIA; LEUKOCYTE ACTIVATION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT; REPERFUSION;

EID: 0032693852     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5746     Document Type: Article

References (27)

1. Formela L. J., Galloway S. W., Kingsnorth A. N. Inflammatory mediators in acute pancreatitis. Br. J. Surg. 82:1995;6.
2. Sun Z. W., Wang X. D., Deng X. M., Wallen R., Lasson Å., Johansson E., Andersson R. Bidirections of intestinal barrier permeability, cellular membrane system integrity, proteinase inhibitors, and cell death after intestinal ischemia and reperfusion in rats. Shock. 10:1998;203.
3. Franciose R. J., Moore E. E., Moore F. A., Read R. A., Carl V. S., Banerjee A. Hypoxia/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism. J. Surg. Res. 61:1996;459.
4. Sun Z. W., Wang X. D., Deng X. M., Åke L., Soltesz V., Börjesson A., Andersson R. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. Dig. Surg. 1999.
5. Milhoan K., Lane T., Bloor C. Hypoxia induces endothelial cells to increase their adherence for neutrophils: Role of PAF. Am. J. Physiol. 263:1992;956.
6. Kingsnorth A. N., Galloway S. W., Formela L. J. Randomized, double phase II trial of lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. Br. J. Surg. 82:1995;1414.
7. Simpson R., Alon R., Kobzik L., Valeri R., Shepro D., Hechtman H. B. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann. Surg. 218:1993;444.
8. Sun Z. W., Wang X. D., Deng X. M., Gefors L., Hallberg E., Wallen R., Andersson R. The influence of circulatory and gut luminal challenges on bidirectional intestinal barrier permeability in rats. Scand. J. Gastroenterol. 32:1997;37.
9. Mansilla-Roselló A., Ferrón-Orihuela J., Ruiz-Cabello F., Garrote-Lara D., Fernández-Mondéjar E., Delgado-Carrasco M. Differential effects of IL-1β and ibuprofen after endotoxic challenge in mice. J. Surg. Res. 67:1997;199.
10. Bradley P. P., Priebat D. A., Christensen R. D., Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:1982;206.
11. Laurell C. B. Electroimmunoassay. Scand. J. Clin. Lab. Invest. 29:1972;21.
12. Gallimore M. J., Friberger P. Chromogenic peptide substrate assays and their clinical applications. Blood Rev. 5:1991;117.
13. Crissinger K. D., Kvietys P. R., Granger D. N. Pathophysiology of gastrointestinal mucosa permeability. J. Intern. Med. 228:1990;145.
14. Kubes P. Ischemia-reperfusion in feline small intestine: A role for nitric oxide. Am. J. Physiol. 264:1993;G143.
15. Scannell G. Leukocyte responses to hypoxic/ischemic conditions. New Horiz. 4:1996;179.
16. Chao W., Olson M. S. Platelet-activating factor: Receptors and signal transduction. Biochem. J. 292:1993;617.
17. Arndt H., Kubes P., Granger D. N. Involvement of neutrophils in ischemia-reperfusion injury in the small intestine. Klin. Wochenschr. 69:1991;1056.
18. Kurtek H., Zhang S., Tso P., Granger D. N. Granulocyte accumulation in different layers of small intestine during ischemia-reperfusion: Role of leukocyte adhesion glycoprotein. Gastroenterology. 100:1991;A223.
19. Brower M. S., Harpel P. C. Proteolytic cleavage and inactivation of α-2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase. J. Biol. Chem. 257:1982;9849.
20. Toyama M. T., Lewis M. P. N., Kusske A. M., Reber P. U., Ashley S. W., Reber H. A. Ischemia-reperfusion mechanisms in acute pancreatitis. Scand. J. Gastroenterol. 31:1996;20.
21. Risberg B. Fibrinolysis in relation to lungs and ARDS. Aasen A. O., Risberg B. Surgical Pathophysiology. 1990;289-316 Harwood Academic, London.
22. Sappono A. P., Huarte J., Vassalli J., Belin D., Kiss J. Z., Wohlwend A., Vassali J. D. Extracellular proteolysis in the adult murine brain. J. Clin. Invest. 92:1993;678.
23. Barrett A. J., Starkey P. M. The interaction of alpha-2-macroglobulin with proteinases. Biochem. J. 133:1973;709.
24. Borth W. Alpha-2-macroglobulin: A multifunctional and targeting protein with possible roles in immunity and autoimmunity. Ann. NY Acad. Sci. 737:1994;267.
25. Pastores S. M., Katz D. P., Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am. J. Gastroenterol. 91:1996;1697.
26. Bone R. C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation. Crit. Care Med. 24:1996;163.
27. Ley K. The splanchnic microcirculation: Cytokines and cell adhesion molecules. Pinsky M. R., Dhainaut I. F., Artigas A. The Splanchnic Circulation: Update in Intensive Care and Emergency Medicine. 1995;27-38 Springer-Verlag, New York.